Drug Therapy Research Award

2007
“Time Until Initiation of Fluconazole Therapy Impacts Mortality in Patients With Candidemia: A Multi-Institutional Study”
Kevin W. Garey, Pharm.D., M.S., Milind Rege, M.S., Manjunath P. Pai, Pharm.D., Dana E. Mingo, Pharm.D., Katie J. Suda, Pharm.D., Robin S. Turpin, Ph.D., and David T. Bearden, Pharm.D.
Clinical Infectious Diseases 2006; 43(July1):25-31.
University of Houston College of Pharmacy and St. Luke’s Episcopal Hospital
Houston, TX

2006
“The Impact of ACE Inhibitors or Angiotension II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes”
Craig I. Coleman, Pharm.D., C. Michael White, Pharm.D., FCCP, FCP, Effie L. Kuti, Pharm.D., Michael J. Kardas, Pharm.D., and Michael Lindberg, M.D.
Diabetes Care 2005; 28:2261-2266
University of Connecticut School of Pharmacy, Storrs, CT
Hartford Hospital, Hartford, CT

2005

“Electrocardiographic and Hemodynamic Effects of a Multicomponent Dietary Supplement Containing Ephedra and Caffeine: A Randomized Controlled Trial”
Brian F. McBride, Pharm.D.; Angeliki K. Karapanos, R.Ph.; Agnes Krudysz, BSN, R.Ph.; Jeffrey Kluger, M.D.; Craig I. Coleman, Pharm.D.; C. Michael White, Pharm.D.
JAMA 2004; 291: 216-221
University of Connecticut Schools of Pharmacy and Medicine, Storrs and Farmington, CT
Hartford Hospital, Hartford, CT

2004
“Intravenous Plus Oral Amiodarone, Atrial Septal Pacing, or Both Strategies to Prevent Post-Cardiothoracic Surgery Atrial Fibrillation: The Atrial Fibrillation Suppression Trial II (AFIST II)”
C. Michael White, Pharm.D.; Michael F. Caron, Pharm.D.; James S. Kalus, Pharm.D.; Heidi Rose, R.N.; Jessica Song, Pharm.D.; Prabashni Reddy, Pharm.D.; Robert Gallagher, M.D., Jeffrey Kluger, M.D.
Circulation, 2003;108[suppl II]:II-200-II-206.
Hartford Hospital, Hartford, CT

2003
"Association Between CYP2CP Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy"
Michelle K. Higashi, Ph.D.; David L. Veenstra, Pharm.D., Ph.D.; L. Midori Kondo, Pharm.D.; Ann K. Wittkowsky, Pharm.D.; Sengkeo L. Srinouanprachanh, B.S.; Fred M. Farin, M.D.; and Allan E. Rettie, Ph.D.
Pharmaceutical Outcomes Research and Policy Program
Universtiy of Washington, Seattle

2002
"Oral Amiodarone for Prevention of Atrial Fibrillation After Open-Heart Surgery, the Atrial Fibrillation Suppression Trial (AFIST): A Randomised, Placebo-Controlled Trial"
Satyendra Giri, M.D., Brigham & Women's Hospital, Harvard University, Boston MA; C. Michael White, Pharm.D., Hartford Hospital, Hartford, CT; Alisha B. Dunn, Pharm.D., Northeastern University, Boston, MA; Kathy Felton, R.N., Linda Freeman-Bosco, R.N., and Prabashni Reddy, Pharm.D., Hartford Hospital, Hartford, CT; James P. Tsikouris, Pharm.D., Texas Tech University, Lubbock; and Heather A. Wilcox, R.N., and Jeffrey Kluger, M.D., Hartford Hospital, Hartford, CT.
The Lancet 2001; 357 [March 17]:830-836.

2001
"Cyclosporine-Drug Interactions and the Influence of Patient Age"
Jennifer Lill, Pharm.D.
University of Washington Medical Center
Larry A. Bauer, Pharm.D.; John R. Horn, Pharm.D.; and Philip D. Hasten, Pharm.D.
Department of Pharmacy and Laboratory Medicine
University of Washington, Seattle